USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions. 1 October 2024
Paris-based asset manager Kurma Partners has raised 140 million euros ($154 million), successfully completing the first closing of Biofund IV 4 October 2024
Caliway Biopharmaceuticals has successfully completed its initial public offering, raising NT$6.4 billion ($206 million), the largest IPO in Taiwan's biotech industry to date. 3 October 2024
Shares of UK drug developer Hemogenyx Pharmaceuticals rose as much as 9% and closed up 5.9% at 1.70 pence yesterday on the news of a further investment from Prevail Partners. 3 October 2024
UK-based biotech Resolution Therapeutics has announced the completion of a £63.5 million ($76.8 million) series B financing round led by Syncona. 3 October 2024
UK-based biotech LoQus23 Therapeutics has closed a £35 million ($43 million) series A financing round, led by Forbion, with support from SV Health Investors' Dementia Discovery Fund and Novartis Venture Fund. 2 October 2024
USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions. 1 October 2024
Boston, USA-based biotech Aktis Oncology, which is targeting alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced the successful closing of an oversubscribed and upsized $175 million Series B financing. 1 October 2024
Chicago, USA-based ARCH Venture Partners revealed it has closed the ARCH Venture Fund XIII, a venture capital fund with more than $3 billion to support the founding and growth of early-stage biotechnology companies. 27 September 2024
USA-based biotech funder and incubator Flagship Pioneering yesterday unveiled Mirai Bio, a company pioneering the first open end-to-end platform for the biotech industry to enable the co-creation of fully optimized genetic medicines. 27 September 2024
The UK government has released a position paper outlining its vision for Framework Programme 10 (FP10), a successor to Horizon Europe, the EU's flagship research collaboration program. 26 September 2024
Italian biotech Genespire—which is developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases—has announced the closing of a 46.6 million euros ($52 million) Series B financing. 25 September 2024
Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of offering affordable care to employees and their families. 25 September 2024
Rare disease firm bluebird bio has announced a company-wide restructuring aimed at cutting costs by 20% and achieving quarterly cash flow break-even by the second half of 2025. 25 September 2024
Aptadir Therapeutics, a biotech company focused on RNA inhibitor-based therapies for cancer and genetic conditions, has launched with $1.6 million in pre-seed funding. 24 September 2024
Australian biotech company Telix Pharmaceuticals is to acquire USA-based RLS Radiopharmacies, expanding its manufacturing and distribution footprint in North America. 24 September 2024
British biotech Vicebio has secured $100 million in a series B funding round to accelerate the development of its next-generation vaccines against respiratory viruses. 23 September 2024
The UK medical research charity LifeArc has already struck gold once in the medical discovery world through its involvement with Keytruda (pembrolizumab), the big-selling immuno-oncology drug sold by US pharma giant Merck & Co. 20 May 2019
New York-based Schrödinger yesterday announced that several new investors have joined its latest funding round, which was completed with a total raise of $110 million to support continued advancement of the company’s industry-leading computational platform and expansion of its therapeutic pipeline. 20 May 2019
ElevateBio has closed a $150 million series A financing round and launched a full-spectrum cell and gene therapy incubator called ElevateBio BaseCamp, in Cambridge, USA. 14 May 2019
Companies developing cell therapies for heart failure, compounds to treat obesity and peptide vaccines for cancer were among those that presented their pitches as part of a Japanese program to boost start-ups in the pharmaceutical sector. 9 May 2019
Europe’s largest privately-held biopharmaceutical company BioNTech has bought antibody assets and infrastructure from San Diego, USA-based MabVax Therapeutics. 9 May 2019
Shares of Clovis Oncology closed up 4.12% at $18.44 yesterday, after the US biotech firm revealed an agreement for up to $175 million in non-dilutive clinical trial financing with certain affiliates of TPG Sixth Street Partners to reimburse Clovis’ costs and expenses related to the ATHENA clinical trial. 3 May 2019
Hutchinson China MedTech Limited has never downplayed the extent of its ambition to put Chinese drug development on the map, so clearly it has not held back with the hyperbole on announcing its upcoming global offering on the Stock Exchange of Hong Kong (SEHK). 15 April 2019
Chinese drugmaker Hansoh Pharmaceutical Group has re-filed its application for an initial public offering (IPO) in Hong Kong, according to sources quoted by Reuters. 15 April 2019
UK-based asset manager Investment Group Capital (IGC) and French healthcare-focused investment platform Mérieux Equity Partners have agreed to acquire DOC Generici from CVC Capital Partners. 9 April 2019
Shares in Japanese oncology specialist Oncolys Biopharma closed 18% up on Monday after the announcement of a deal with Chugai Pharmaceutical, part of Swiss pharma giant Roche. 8 April 2019
SpringWorks Therapeutics, the start-up set up by US pharma giant Pfizer to take forward a number of drug programs, has raised $125 million in a Series B financing. 2 April 2019
UK-based investment firm Cambridge Innovation Capital (CIC) has raised £150 million ($195 million) for investment in life science businesses in the Cambridge area. 2 April 2019
A joint research project between Japanese drugmaker Chugai Pharmaceutical and the Agency for Science, Technology and Research, Singapore (A*STAR) has been awarded a grant by the Global Health Innovative Technology Fund (GHIT Fund). 1 April 2019
The growth of the UK’s biotech sector stands in stark and impressive contrast to many other elements of an economy that is being stagnated by financial and economic uncertainty. 28 March 2019
Immuno-oncology (I-O) company Elicio Therapeutics has launched with a $30 million financing to treat a range of cancers with a new vaccine and immunotherapy platform. 28 March 2019
Kyoto University Innovation Capital and Japanese drugmaker Sumitomo Dainippon Pharma today announced the establishment of AlphaNavi Pharma as a carve-out business venture from Sumitomo Dainippon Pharma, and allocated new shares to third-parties. 28 March 2019
Ringing the opening bell at the Nasdaq stock exchange on Wednesday, Lille-based biotech Genfit (EPA: GNFT) celebrated its listing in New York, raising 130 million euros ($146 million) in the process. 28 March 2019
Despite Brexit uncertainty, investment in the UK’s biotech sector has gone up 65% since 2016, with annual investment reaching £2.2 billion ($2.9 billion) in 2018. 22 March 2019
A pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news